Drug Allergy
|
group |
Immune System Diseases; Chemically-Induced Disorders
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
3 |
|
2006 |
2010 |
Asthma, Aspirin-Induced
|
disease |
Respiratory Tract Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
25
|
6
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Immediate hypersensitivity
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
IgE RESPONSIVENESS, ATOPIC
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
|
0 |
|
|
|
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.200 |
None |
1.000 |
25 |
4
|
2000 |
2018 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.120 |
None |
1.000 |
2 |
1
|
1998 |
2011 |
Allergic rhinitis (disorder)
|
disease |
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
446
|
176
|
0.110 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
ATOPIC ASTHMA, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Allergic asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
371
|
55
|
0.020 |
None |
1.000 |
2 |
1
|
2000 |
2014 |
IgE-mediated allergic asthma
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
133
|
46
|
0.020 |
None |
1.000 |
2 |
1
|
2000 |
2014 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
751
|
232
|
0.020 |
None |
1.000 |
2 |
1
|
1998 |
2011 |
Allergic sensitization
|
disease |
|
Disease or Syndrome
|
85
|
26
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atopic disorders
|
group |
|
Disease or Syndrome
|
29
|
2
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Cockayne Syndrome, Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
80
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sleep Apnea, Central
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
122
|
17
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Vitelliform Macular Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
74
|
120
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Childhood asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
303
|
317
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
anaphylaxis
|
phenotype |
Immune System Diseases
|
Disease or Syndrome
|
180
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Child Sexual Abuse
|
phenotype |
|
Mental or Behavioral Dysfunction
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Shigella Infections
|
group |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
121
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Helminthiasis
|
disease |
Infections
|
Disease or Syndrome
|
59
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |